Latest Market Investments News

Page 5 of 8
Cettire Limited reported FY25 results showing stable sales revenue and a breakeven adjusted EBITDA despite a challenging luxury goods market. The company’s strategic focus on profitability, supply chain expansion, and emerging markets diversification underpins its resilience.
Logan Eniac
Logan Eniac
29 Aug 2025
Cettire Limited reported stable revenue for FY25 despite a challenging luxury market, but profitability sharply declined due to increased promotional activity and softer demand.
Logan Eniac
Logan Eniac
29 Aug 2025
Future Generation Australia reports a notable drop in half-year profits for 2025 but announces an increased fully franked interim dividend, reflecting confidence in its long-term investment strategy and social impact commitments.
Claire Turing
Claire Turing
28 Aug 2025
Airtasker Limited reported a robust FY25 with double-digit revenue growth and positive free cash flow, underpinned by strong Australian performance and rapid expansion in the UK and US markets.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Airtasker Limited reported a 12.8% increase in revenue to $52.6 million for FY25, driven by growth in Australia, the UK, and the US. However, the company’s net loss widened significantly to $37.7 million, reflecting heavy investment in global marketing and media partnerships.
Sophie Babbage
Sophie Babbage
28 Aug 2025
WAM Alternative Assets Limited has announced a 15.4% increase in its fully franked final dividend, reflecting robust portfolio gains and a confident outlook under Wilson Asset Management's stewardship.
Victor Sage
Victor Sage
28 Aug 2025
Kogan.com Ltd reported robust FY25 growth driven by its core platform, despite setbacks from Mighty Ape's platform migration. The company declared a solid dividend and outlined a cautious but optimistic FY26 outlook.
Logan Eniac
Logan Eniac
25 Aug 2025
Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.
Ada Torres
Ada Torres
25 Aug 2025
Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.
Ada Torres
Ada Torres
25 Aug 2025
GQG Partners reported a robust first half of 2025 with funds under management rising to US$172.4 billion and net revenue increasing 11%, driven by solid net inflows and capital appreciation. The firm also expanded its product suite, including launching an active ETF, while maintaining strong investment performance across strategies.
Claire Turing
Claire Turing
22 Aug 2025
Bega Cheese Limited reported a robust FY2025 with a 23% rise in normalised EBITDA to $202 million, underpinned by branded growth and a turnaround in its bulk segment. Strategic manufacturing rationalisation and new product innovation set the stage for continued momentum.
Victor Sage
Victor Sage
21 Aug 2025
Magellan Financial Group reported a solid FY25 with an 8.2% rise in assets under management and a notable surge in strategic partnership income, offsetting a dip in investment management revenue.
Claire Turing
Claire Turing
20 Aug 2025